1. A multi-modality, multi-parametric phenotyping study of transthyretin amyloid cardiomyopathy associated with the p.V142I TTR variant. (3rd October 2022) Authors: Razvi, Y; Ioannou, A; Chacko, L; Patel, R; Ganesananthan, S; Kaza, N; Blakeney, I; Porcari, A; Masi, A; Venneri, L; Rauf, M U; Martinez-Naharro, A; Hawkins, P N; Fontana, M; Gillmore, J Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cardiac transplantation in transthyretin amyloid cardiomyopathy: outcomes from three decades of tertiary centre experience. (3rd October 2022) Authors: Razvi, Y; Patel, R; Ioannou, A; Rauf, M U; Masi, A; Porcari, A; Blakeney, I; Kaza, N; Lachmann, H; Whelan, C; Venneri, L; Martinez-Naharro, A; Hawkins, P; Fontana, M; Gillmore, J D Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Changes in referral pathway and phenotypic status of patients diagnosed with ATTR cardiac amyloidosis during the past 20 years. (3rd October 2022) Authors: Ioannou, A; Patel, R K; Razvi, Y; Porcari, A; Venneri, L; Bandera, F; Masi, A; Williams, G E; O'Beara, S; Ganesananthan, S; Martinez-Naharro, A; Chacko, L; Hawkins, P N; Gillmore, J D; Fontana, M Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Multi-imaging characterisation of cardiac phenotype in different types of amyloidosis. (3rd October 2022) Authors: Ioannou, A; Patel, R K; Razvi, Y; Porcari, A; Knight, D; Martinez-Naharro, A; Kotecha, T; Venneri, L; Chacko, L; Hawkins, P N; Gillmore, J D; Fontana, M Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Myocardial ischaemia in cardiac amyloidosis: a change of perspective. (3rd October 2022) Authors: Ioannou, A; Chacko, L; Kotecha, T; Patel, R K; Razvi, Y; Porcari, A; Venneri, L; Martinez-Naharro, A; Knight, D; Brown, J; Hawkins, P N; Gillmore, J D; Fontana, M Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P-292Prognostic role white blood cell levels in patients with advanced pancreatic adenocarcinoma undergoing first-line chemotherapy. (2nd July 2019) Authors: Ioannou, A; Demiri, S; Papaxoinis, G; Rapti, V; Klouva, E; Sarris, E; Baxevanos, P; Garefalakis, G; Goumas, G; Gouveris, P; Kourakos, P; Koumakis, G Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Prognostic implications of clinical phenotype and severity of cardiac involvement in patients presenting with immunoglobulin light chain amyloidosis. (3rd October 2022) Authors: Porcari, A; Masi, A; Ioannou, A; Patel, R K; Razvi, Y; Venneri, L; Martinez-Naharro, A; Sinagra, G; Wechelakar, A; Hawkins, P N; Gillmore, J D; Fontana, M Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Progression, regression and redefining the treatment response – cardiac magnetic resonance with T1 and extracellular volume mapping in cardiac light-chain amyloidosis. (3rd October 2022) Authors: Patel, R; Martinez-Naharro, A; Kotecha, T; Karia, N; Ioannou, A; Petrie, A; Chacko, L; Razvi, Y; Lachmann, H; Venneri, L; Kellman, P; Gillmore, J; Hawkins, P; Wechalekar, A; Fontana, M Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Size matters - redefining sex differences among patients with transthyretin amyloid cardiomyopathy – have we been wrong all along?. (3rd October 2022) Authors: Patel, R; Ioannou, A; Razvi, Y; Chacko, L; Venneri, L; Martinez-Naharro, A; Masi, A; Lachmann, H; Wechalekar, A; Petrie, A; Whelan, C; Hawkins, P; Gillmore, J; Fontana, M Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗